Walgreens Boots Alliance (BUE:WBA) EBITDA Margin %: 1.60% (As of May. 2025) — 70% Below Median


What is Walgreens Boots Alliance EBITDA Margin %?

Walgreens Boots Alliance BUE:WBA 15 EBITDA Margin % is 1.60% as of May. 2025, which is 70% below its 10-year median of 5.34. GuruFocus rates BUE:WBA with a GF Score™ of 15/100. The stock has 7 warning signs investors should review.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Walgreens Boots Alliance's EBITDA for the three months ended in May. 2025 was ARS738,574.99 Mil. Walgreens Boots Alliance's Revenue for the three months ended in May. 2025 was ARS46,144,366.32 Mil. Therefore, Walgreens Boots Alliance's EBITDA margin for the quarter that ended in May. 2025 was 1.60%.


Walgreens Boots Alliance  (BUE:WBA) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Walgreens Boots Alliance EBITDA Margin % Related Terms


Walgreens Boots Alliance EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Walgreens Boots Alliance's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Walgreens Boots Alliance EBITDA Margin % Chart

Walgreens Boots Alliance Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.45 3.68 4.80 -1.86 -7.64

Walgreens Boots Alliance Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.67 -0.65 0.53 -9.09 1.60

BUE:WBA vs WGRX, PETS, BHIC: EBITDA Margin % Comparison

For the Pharmaceutical Retailers subindustry, Walgreens Boots Alliance's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Walgreens Boots Alliance EBITDA Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Walgreens Boots Alliance's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Walgreens Boots Alliance's EBITDA Margin % falls into.



Walgreens Boots Alliance EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Walgreens Boots Alliance's EBITDA Margin % for the fiscal year that ended in Aug. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Aug. 2024 )/Revenue (A: Aug. 2024 )
=-10511095.739/137617252.587
=-7.64 %

Walgreens Boots Alliance's EBITDA Margin % for the quarter that ended in May. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: May. 2025 )/Revenue (Q: May. 2025 )
=738574.991/46144366.318
=1.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 1.60% mean?
Walgreens Boots Alliance (BUE:WBA) has a EBITDA Margin % of 1.60% as of May. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Walgreens Boots Alliance and its competitors. This is 70% below median its historical median of 5.34.
Is Walgreens Boots Alliance's EBITDA Margin % too high?
Walgreens Boots Alliance's current EBITDA Margin % of 1.60% is 70% below median its 10-year median of 5.34. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Walgreens Boots Alliance's value of 1.60% is 84.3% below this industry median. Overall, Walgreens Boots Alliance has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Walgreens Boots Alliance's EBITDA Margin % compare to WGRX and PETS?
Walgreens Boots Alliance's EBITDA Margin % of 1.60% can be compared against companies in the Healthcare Providers & Services industry. The industry median EBITDA Margin % is 10.21. Walgreens Boots Alliance's value of 1.60% is 84.3% below this benchmark. While the company's 10-year median is 5.34 vs. the industry median of 10.21, Walgreens Boots Alliance has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Walgreens Boots Alliance's current EBITDA Margin % of 1.60% is 84.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Walgreens Boots Alliance and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Walgreens Boots Alliance's current EBITDA Margin % is 1.60%, which is 70% below median its own 10-year median of 5.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Walgreens Boots Alliance stock overvalued right now?
Walgreens Boots Alliance (BUE:WBA) has a current EBITDA Margin % of 1.60%. The current EBITDA Margin % is 1.60%, which is 70% below median its 10-year median of 5.34 and 84.3% below the Healthcare Providers & Services industry median of 10.21. Walgreens Boots Alliance's overall GF Score™ is 15/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Walgreens Boots Alliance (BUE:WBA), the current EBITDA Margin % is 1.60% as of May. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Walgreens Boots Alliance Business Description

Address 108 Wilmot Road, Deerfield, IL, USA, 60015
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.